文献速递肾小球疾病遗传性与小管间质肾病

聚类分析识别C3肾小球病/免疫复合物介导膜增生性肾小球肾炎的不同致病模式

Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
PubMed 文献 · J Am Soc Nephrol · 2017-10-13

该研究对173例C3G/IC-MPGN患者进行无监督层次聚类,基于组织学、遗传学、临床及补体参数数据,识别出四个致病模式不同的聚类。聚类1-3为液相补体激活,表现为低血清C3、遗传/获得性替代途径异常高发;聚类4为固相补体激活,血清C3正常或轻度异常、发病晚、肾脏生存差。研究还提供简单算法将患者分配至特定聚类。

要点

  • C3G/IC-MPGN可分为四个致病模式聚类,液相与固相补体激活是核心区分。
  • 液相激活聚类中,聚类2兼有经典途径激活且肾病综合征起病比例最高。
  • 固相激活聚类(4)血清C3正常或轻度异常,发病晚且肾脏生存差。

核心结论

  • C3G/IC-MPGN存在四个基于补体激活模式的致病聚类,有助于阐明病因、改善ESRD风险评估并推动个体化治疗。

研究设计与样本

  • 对173例C3G/IC-MPGN患者进行无监督层次聚类,纳入组织学、遗传学、临床及血清/血浆补体参数数据。

主要发现

  • 聚类1-3为液相补体激活,血清C3低且遗传/获得性替代途径异常高发;聚类4为固相激活,血清C3正常或轻度异常、发病晚、肾脏生存差。
  • 聚类1和2有大量替代途径激活包括终末途径激活,且内皮下沉积比例最高;聚类2额外有经典途径激活且起病时肾病综合征比例最高。
  • 聚类3以C3转化酶激活为主,并见高度电子致密的膜内沉积物。

关键数值与推荐

  • 研究提供简单算法将C3G/IC-MPGN患者分配至特定聚类。

临床怎么用

  • 临床可依据补体激活模式(液相 vs 固相)及聚类特征对C3G/IC-MPGN进行风险分层,指导个体化治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Membranoproliferative GN (MPGN) was recently reclassified as alternative pathway complement-mediated C3 glomerulopathy (C3G) and immune complex-mediated membranoproliferative GN (IC-MPGN). However, genetic and acquired alternative pathway abnormalities are also observed in IC-MPGN. Here, we explored the presence of distinct disease entities characterized by specific pathophysiologic mechanisms. We performed unsupervised hierarchical clustering, a data-driven statistical approach, on histologic, genetic, and clinical data and data regarding serum/plasma complement parameters from 173 patients with C3G/IC-MPGN. This approach divided patients into four clusters, indicating the existence of four different pathogenetic patterns. Specifically, this analysis separated patients with fluid-phase complement activation (clusters 1-3) who had low serum C3 levels and a high prevalence of genetic and acquired alternative pathway abnormalities from patients with solid-phase complement activation (cluster 4) who had normal or mildly altered serum C3, late disease onset, and poor renal survival. In patients with fluid-phase complement activation, those in clusters 1 and 2 had massive activation of the alternative pathway, including activation of the terminal pathway, and the highest prevalence of subendothelial deposits, but those in cluster 2 had additional activation of the classic pathway and the highest prevalence of nephrotic syndrome at disease onset. Patients in cluster 3 had prevalent activation of C3 convertase and highly electron-dense intramembranous deposits. In addition, we provide a simple algorithm to assign patients with C3G/IC-MPGN to specific clusters. These distinct clusters may facilitate clarification of disease etiology, improve risk assessment for ESRD, and pave the way for personalized treatment.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Iatropoulos P, Daina E, Curreri M, et al. Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN. J Am Soc Nephrol. 2017. PMID: 29030465. doi:10.1681/ASN.2017030258

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。